| Literature DB >> 36041832 |
Teresa De Sanctis1, Mary-Ann Etiebet2, Wendy Janssens3, Mark H van der Graaf1, Colette van Montfort1, Emma Waiyaiya4, Nicole Spieker5.
Abstract
In Kenya, early coronavirus disease (COVID-19) modeling studies predicted that disruptions in antenatal care and hospital services could increase indirect maternal and neonatal deaths and stillbirths. As the Kenyan government enforced lockdowns and a curfew, many mothers-to-be were unable to safely reach hospital facilities, especially at night. Fear of contracting COVID-19, increasing costs of accessing care, stigma, and falling incomes forced many expectant mothers to give birth at home. MomCare, which primarily serves communities in remote areas and urban slums, links mothers-to-be with payers and health care providers, following a standardized pregnancy program based on World Health Organization guidelines at a predetermined cost and quality. Expectant mothers gain access to care through a mobile wallet on their feature phone (voice, text, and basic internet), and providers are paid after appropriate care is given. Within the first 3 weeks of the pandemic in Kenya, the following services were added to the MomCare bundle: emergency ambulance services during curfew hours, extended bed allowances to encourage early care, phone calls to check on mothers approaching their delivery dates and to promote the generation of a birth plan, SMS messages to inform mothers of open facilities and COVID-19 protocols, and training for clinic staff in managing COVID-19 patients and infection prevention. We compare data collected through the MomCare platform during the 6 months before the first confirmed COVID-19 case in Kenya (September 2019-February 2020) with data collected during the 6 months that followed. This study shows that care-seeking behaviors (enrollment, antenatal/postnatal care, skilled deliveries) increased for mothers-to-be enrolled in MomCare during the COVID-19 lockdowns, while quality of care and outcomes were maintained. Public health practitioners can promote interactive, patient-driven technology like MomCare to augment traditional responses, quickly linking payments with patients and providers in times of crisis. © De Sanctis et al.Entities:
Mesh:
Year: 2022 PMID: 36041832 PMCID: PMC9426986 DOI: 10.9745/GHSP-D-21-00665
Source DB: PubMed Journal: Glob Health Sci Pract ISSN: 2169-575X
FIGURE 1MomCare Theory of Action
Abbreviations: ANC, antenatal care; COVID-19, coronavirus disease; IT, information technology; SMS, short message service.
FIGURE 2The MomCare Mother Journey, Bundle Composition, and 5 COVID-19 Support Interventions
Abbreviations: ANC, antenatal care; COVID-19, coronavirus disease; IMM, immunizations; MNCH, maternal, neonatal, and child health; PNC, postnatal care; SMS, short message service.
Maternal and Child Health Care Outcomes in Kenya Before and During COVID-19
|
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| ||
| Panel A. Percentage of women with a skilled/complicated/normal/cesarean/referred delivery out of all women who enrolled in MomCare during the | ||||||||||
| Percentage of skilled deliveries | Before | 12.2 | 3.19 | 0.000 | 9.0 | 3.16 | 0.000 | 8.2 | 1.72 | 0.000 |
| During | 17.2 | 4.79 | 18.3 | 8.09 | 16.0 | 4.77 | ||||
| Percentage of complicated deliveries | Before | 3.1 | 1.97 | 0.012 | 2.0 | 2.10 | 0.067 | 1.0 | 1.55 | 0.175 |
| During | 0.0 | 0.00 | 0.0 | 0.00 | 0.0 | 0.00 | ||||
| Percentage of normal deliveries | Before | 77.6 | 3.41 | 0.678 | 85.3 | 7.81 | 0.519 | 78.3 | 11.08 | 0.010 |
| During | 80.0 | 3.58 | 87.3 | 1.03 | 82.0 | 3.90 | ||||
| Percentage of cesarean deliveries | Before | 19.3 | 3.49 | 0.172 | 12.3 | 5.99 | 0.00 | 20.5 | 10.58 | 0.000 |
| During | 19.8 | 3.82 | 12.7 | 1.03 | 18.0 | 3.90 | ||||
| Percentage of deliveries through referral | Before | 17.8 | 3.13 | 0.329 | 0.8 | 1.17 | 0.001 | 0.0 | 0.00 | 0.102 |
| During | 17.0 | 2.00 | 4.8 | 1.72 | 0.7 | 0.82 | ||||
| Panel B. Percentage of women who were classified at some point during their pregnancy as having a medium- or high-risk pregnancy out of all women who | ||||||||||
| Percentage of medium-risk mothers | Before | 32.5 | 3.21 | 0.616 | 16.5 | 1.38 | 0.157 | 37.2 | 4.07 | 0.000 |
| During | 29.3 | 0.82 | 20.2 | 1.94 | 24.0 | 3.69 | ||||
| Percentage of high-risk mothers | Before | 35.2 | 2.64 | 0.324 | 43.2 | 3.60 | 0.848 | 36.0 | 4.34 | 0.000 |
| During | 38.5 | 2.59 | 45.2 | 0.41 | 45.5 | 5.09 | ||||
| Panel C. Percentage of women (newborns) who received the listed diagnostic tests and supplements out of all women who enrolled in MomCare | ||||||||||
| Percentage of mothers with ANC profile test | Before | 73.3 | 8.38 | 0.000 | 69.0 | 6.90 | 0.368 | 70.3 | 3.78 | 0.000 |
| During | 60.0 | 16.94 | 70.7 | 2.50 | 52.5 | 11.17 | ||||
| Percentage of mothers with blood pressure at each visit | Before | 19.0 | 7.24 | 0.000 | 92.7 | 1.75 | 0.991 | 85.7 | 15.63 | 0.000 |
| During | 42.3 | 7.87 | 91.5 | 1.87 | 83.7 | 10.25 | ||||
| Percentage of mothers with at least one ultrasound | Before | 18.2 | 5.49 | 0.000 | 28.8 | 5.49 | 0.041 | 25.5 | 7.64 | 0.000 |
| During | 20.7 | 5.32 | 24.3 | 4.89 | 16.7 | 2.88 | ||||
| Percentage of mothers with | Before | 71.3 | 4.84 | 0.133 | 85.8 | 4.92 | 0.671 | 87.3 | 8.55 | 0.279 |
| During | 69.0 | 6.45 | 86.2 | 3.31 | 82.0 | 1.55 | ||||
| Percentage of mothers with urine analysis at each visits | Before | 60.3 | 9.93 | 0.000 | 89.2 | 3.37 | 0.948 | 84.5 | 3.27 | 0.881 |
| During | 66.0 | 4.77 | 87.0 | 2.53 | 86.7 | 2.34 | ||||
| Percentage of mothers with oxytocin at delivery | Before | 11.8 | 3.43 | 0.546 | 9.3 | 2.16 | 0.345 | 8.2 | 1.72 | 0.170 |
| During | 12.3 | 1.75 | 11.2 | 1.83 | 10.0 | 1.26 | ||||
| Percentage of mothers with hemoglobin test at delivery | Before | 35.0 | 7.48 | 0.001 | 51.3 | 3.98 | 0.750 | 44.5 | 3.99 | 0.354 |
| During | 32.0 | 5.76 | 49.8 | 2.86 | 43.8 | 7.22 | ||||
| Percentage of newborns with vitamin K | Before | 93.7 | 3.44 | 0.610 | 87.0 | 7.01 | 0.692 | 95.2 | 3.60 | 0.033 |
| During | 86.3 | 3.93 | 87.5 | 1.05 | 82.3 | 3.56 | ||||
Abbreviation: ANC, antenatal care; COVID-19, coronavirus disease; SD, standard deviation; VDRL, venereal disease research laboratory.
Results of Chi-squared test comparisons across the 6 months before the first case of COVID-19 in Kenya (September 2019–February 2020) and the following 6 months (March 2020–August 2020) (data derived as per February 15, 2021).
Significant differences.
P values based on a heteroscedastic unpaired t-test instead of a Chi-squared test since the latter is inconclusive when one of the comparison groups has mean zero throughout.
Definitions: skilled deliveries=births that occur in a health facility connected to MomCare; complicated deliveries=births that include prepartum complications (e.g., obstructed labor) or intrapartum or postpartum hemorrhage; normal delivery=spontaneous or induced vaginal births; medium-risk mothers=mothers whose pregnancies include non-severe complications, including but not limited to asthma, urinary tract infection, candidiasis, or female genital mutilation; high-risk mothers=mothers whose pregnancies include severe complications or high-risk factors including but not limited to: pregnancies in women aged 19 years and younger, pregnancies in women aged 35 years and older; history of cesarean delivery, anemia, hypertension, diabetes, HIV, or pre-eclampsia; mothers with ANC profile test=mothers who received tests to determine blood grouping, hemoglobin (Hb), hepatitis B antigen, HIV test, VDRL test, and a urine analysis.
FIGURE 3Uptake and Results of MomCare COVID-19 Response Initiativesa (A) Women’s utilization of emergency inbound ambulances during curfew; (B) Women’s utilization of extended bed allowance greater than 2 days; (C) Facility-level outcomes associated with the “mothers-to-be calls and birth plan” interventionb
Abbreviation: COVID-19, coronavirus disease.
aFigures show results over the study period March 2020–August 2020.
bActive users are health care providers who logged more than 20 page views of mothers-to-be data; passive users are health care providers who logged 20 or less page views of mothers-to-be data.
FIGURE 4MomCare Use Pre- and Post-COVID-19,a September 2019–August 2020
Abbreviations: ANC, antenatal care; COVID-19, coronavirus disease; IMM, immunizations; PNC, postnatal care.
aMomCare use across the 6 months before the first case of COVID-19 in Kenya (September 2019–February 2020) and the following 6 months (March 2020–August 2020). Data derived February 15, 2021.